Technology

CorMedix

$8.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-1.50%) Today
$0.00 (0.00%) As of 12:18 PM UTC after-hours

Why Robinhood?

You can buy or sell CorMedix and other stocks, options, and ETFs commission-free!

About CRMD

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ. The listed name for CRMD is CorMedix Inc.

CEO
Mohammed Khoso Baluch
Employees
30
Headquarters
Berkeley Heights, New Jersey
Founded
2006
Market Cap
279.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
560.46K
High Today
$8.83
Low Today
$8.39
Open Price
$8.75
Volume
599.11K
52 Week High
$9.42
52 Week Low
$2.16

Collections

CRMD Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 15, After Hours

You May Also Like

DDM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure